Roche set to fully acquire Flatiron Health in $1.9bn deal to accelerate cancer drug development

Roche, the Swiss pharmaceutical giant, has announced its plans to fully acquire Flatiron Health, a leading oncology software company, for $1.9 billion. This strategic move ... Read More